Head-To-Head Review: Pressure BioSciences (OTCMKTS:PBIO) and Envoy Medical (NASDAQ:COCH)

Pressure BioSciences (OTCMKTS:PBIO) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Institutional and Insider Ownership

0.0% of Pressure BioSciences shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 10.8% of Pressure BioSciences shares are held by insiders. Comparatively, 58.9% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for Pressure BioSciences and Envoy Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pressure BioSciences	0	0	0	0	0.00
Envoy Medical	0	0	2	0	3.00

Envoy Medical has a consensus target price of $9.25, suggesting a potential upside of 595.49%. Given Envoy Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than Pressure BioSciences.

Profitability

This table compares Pressure BioSciences and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pressure BioSciences	N/A	N/A	N/A
Envoy Medical	-10,961.26%	N/A	-236.14%

Earnings and Valuation

This table compares Pressure BioSciences and Envoy Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pressure BioSciences	$1.98 million	0.01	-$29.31 million	($0.96)	0.00
Envoy Medical	$222,000.00	128.93	-$20.80 million	($1.43)	-0.93

Envoy Medical has lower revenue, but higher earnings than Pressure BioSciences. Envoy Medical is trading at a lower price-to-earnings ratio than Pressure BioSciences, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Pressure BioSciences has a beta of -0.88, meaning that its share price is 188% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.19, meaning that its share price is 119% more volatile than the S&P 500.

Summary

Envoy Medical beats Pressure BioSciences on 8 of the 13 factors compared between the two stocks.

About Pressure BioSciences

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.